KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Common Equity (2016 - 2026)

Medtronic's Common Equity history spans 14 years, with the latest figure at $49.0 billion for Q1 2026.

  • On a quarterly basis, Common Equity fell 1.27% to $49.0 billion in Q1 2026 year-over-year; TTM through Jan 2026 was $49.0 billion, a 1.27% decrease, with the full-year FY2025 number at $48.0 billion, down 4.75% from a year prior.
  • Common Equity hit $49.0 billion in Q1 2026 for Medtronic, roughly flat from $48.9 billion in the prior quarter.
  • Over the last five years, Common Equity for MDT hit a ceiling of $52.8 billion in Q3 2022 and a floor of $48.0 billion in Q2 2025.
  • Historically, Common Equity has averaged $50.6 billion across 5 years, with a median of $51.4 billion in 2023.
  • Biggest five-year swings in Common Equity: increased 3.5% in 2022 and later fell 6.24% in 2024.
  • Tracing MDT's Common Equity over 5 years: stood at $52.1 billion in 2022, then dropped by 0.79% to $51.6 billion in 2023, then fell by 5.68% to $48.7 billion in 2024, then rose by 0.29% to $48.9 billion in 2025, then grew by 0.26% to $49.0 billion in 2026.
  • Business Quant data shows Common Equity for MDT at $49.0 billion in Q1 2026, $48.9 billion in Q4 2025, and $48.1 billion in Q3 2025.